Qualification & Validation
Qualification & Validation
Quality Assurance
Quality Assurance
Regulatory Affairs
Regulatory Affairs
Clinical
Clinical
Lab Services
Lab Services
Vigilance
Vigilance
Software Solutions & Services
Software Solutions & Services
Tox green
Toxicology
Pharma (2)
Pharma & Biotech
Medical Devices (2)
Medical devices
IVD (2)
In vitro diagnostics
Search QbD Group
  • There are no suggestions because the search field is empty.
Scientific Advice - Regulatory Affairs - QbD Group

Scientific Advice

Seeking scientific advice or protocol assistance during drug development offers numerous benefits. Firstly, it ensures alignment with regulatory requirements, enhancing the likelihood of successful approval. Additionally, it facilitates early identification and resolution of potential regulatory hurdles, saving time and resources. 

Our highly skilled QbD Group experts can guide your project teams, write high-quality briefing books, and help you prepare for the meetings with EMA, FDA, or national agencies or attend them on the client’s behalf. 

At QbD Group, we assist you in interacting with necessary health agencies by guiding you through scientific advice and protocol assistance with EMA, FDA, and national agencies, as well as pre-submission meetings.

Read more

 

Types of scientific advice

An essential step in the early stages of developing a potential medicinal product of a candidate medicinal product is the preparation of the Clinical Trial Application for the First in Human (FIH) clinical trial. 

QbD Group’s experts will guide you through this process and subsequent steps, for example ensuring compliance with EU Pediatric Regulation Requirements, leveraging opportunities for Orphan Drug Status, and actively seeking regulatory authority input through Scientific Advice procedures throughout the development journey. 

What does it entail?

Agency interactions 

Successfully submit your application for drug approval to the competent authorities. Qbd we help you interact with the required agencies. 

Preparation & communication  

Agency interactions play a central role in the drug approval process. For example, in the European Union (EU), a company that wishes to bring a pharmaceutical to the market must submit an application to the competent authority or the European Medicines Agency (EMA) for a ‘marketing authorization’ (license).  

Depending on the procedure, our team of experienced consultants help you to interact with all relevant health authorities:  

  • Centralized procedure: interaction with EMA, (co)-rapporteur, concerned member state. 
  • National, Mutual Recognition Procedure (MRP) and/or a Decentralized Procedure (DCP): interaction with national agencies. 
How can we support
EC-REP - Regulatory Affairs - QbD Group (2)

 

How we support you

We offer a range of specialized services to support your interactions with regulatory authorities. From initiating contact to managing meetings, our experienced team ensures a seamless and effective approach throughout the entire regulatory process.

Initiate authority contact

Initiate authority contact

We assist in establishing initial contact with regulatory authorities, ensuring clear communication and coordination from the start.

Prepare briefing packages

Prepare briefing packages

Our team prepares comprehensive briefing packages to support regulatory submissions and facilitate discussions with authorities.

Moderate authority meetings

Moderate authority meetings

We efficiently manage and moderate meetings with regulatory authorities, ensuring productive and transparent discussions.

Dossier (CMC) guidance

Dossier (CMC) guidance

We provide expert guidance on Chemistry, Manufacturing, and Controls (CMC) dossiers to meet regulatory expectations and ensure compliance.
portrait image - website (22)

Why partner with QbD Group?

EXCEPTIONAL RA SERVICES THAT MEET YOUR NEEDS​ 

Choosing QbD means partnering with a trusted leader in Regulatory Affairs. With over a decade of expertise, we provide tailored support across the entire product lifecycle, ensuring seamless compliance and customer satisfaction on a global scale.

  • 10+ years of experience: benefit from our team of highly qualified consultants. ​
  • Full life cycle support: full support from pre- to the post-marketing phase.​
  • Global presence​: QbD Group operates globally, at QbD Austria with a special focus on Europe (EU) and China.​
  • Customer satisfaction​: constant evaluation, transparency and clear objectives.​ 
Get in touch
doc-mask

Related content

preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
Read more
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
Read more
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
Read more
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
Read more
Discover all

 

contact-mail

Get in touch

Need expert guidance for your scientific advice or protocol assistance?

Our dedicated team provides comprehensive support in interacting with EMA, FDA, and national agencies. From preparing briefing packages to attending meetings, we ensure your project progresses smoothly toward successful approval.

Contact us today for tailored scientific support!








RA_Get in touch